Trial Details
COMPLETEDBasic Information
| Clinical ID | c4352 |
|---|---|
| Identifier | NCT00655135 |
| Trial Title | Phase 2 Study of the Safety and Efficacy of LDP-02 in Mildly to Moderately Active Crohn's Patients |
| Trial URL | Visit Original Page |
Study Information
| Study Results | NO |
|---|---|
| Conditions | Crohn's Disease |
| Interventions | DRUG: LDP-02|DRUG: Placebo |
Participant Information
| Sponsor | Millennium Pharmaceuticals, Inc. |
|---|---|
| City | - |
| Country/Region | - |
Enrollment Criteria
| Sex Requirement | ALL |
|---|---|
| Age Requirement | ADULT, OLDER_ADULT |
Study Design
| Study Type | INTERVENTIONAL |
|---|---|
| Phase | PHASE2 |
Time Information
| Start Date | 2000-02 |
|---|---|
| Primary Completion Date | 2002-06 |
| Completion Date | - |